.. (2 , .-)
- ..., . .., ... . .
. . V . : , , . - -: . , , , , .
, . , : -, , -, , .
, . , , .
, . .
, , .
. , . . . .
. 55 28 - , . 50 5 , , 5 , 20 , , , .
. 12, 13, 14, 17, 25, 26, 33, 41, 43, 47 , , 18% . 2, 3, 4, 5, 6, 7, 8, 9, 11, 16, 35, 36, 44, 45, 46, 42 % . , 70%.
|
|
: , 18 % 24% . , 60% 32%, 20 , 24 % .
.. (5 , . -), .. (5 , . -)
..., . ..
. (, , D) - [ .. ., 2006, .., 2010, .., 2008].
. (, , ) .
. 113 , . F3-F4 Metavir.
. : 51,33% (58) ; 48,67% (55) . 61,06% (69) - , 38,94% (44) . 17 74 . 17-20 1,77% (2); 20-29 13,27% (15); 30-39 23,01% (26); 40-49 26,55% (30); 50-59 23,89% (27); 60-69 8,85% (10); 70-74 2,65% (3). : 22,12% (25), 15,93% (18), 13,27% (15). , 51,33% (58), - 48,67% (55). : HCV 78,76% (89); HBV 12,39% (14); HBV+HV 4,42% (5); HBV+HDV 3,54% (4); HBV+HCV+HDV 0,88% (1). , - (HBV+HV, HBV+HDV, HBV+HCV+HDV) 8,85% (10) . : 58,41% (66); 29,20% (33). 23,01% (26) , 76,99% (87 ) - . F3-F4 : 2 51,79% (58), 2 5 24,11% (27), 6 24,11% (27).
. (, , ) .